<div style="text-align:center;">
    <h1>Surgical Day</h1>
</div>
<div style="text-align:left;"></div>
<h3>Holding Area</h3>
<ol>
    <li>Obtain weight and height and record in the EMR.</li>
    <li>Draw ordered lab work. Send for diagnostic testing if indicated.</li>
    <li>Arrange for EKG if ordered.</li>
    <li>Sign and witness surgical and anesthesia consent.</li>
</ol>
</div>
<h3>Intra-Operative Management</h3>

Equipment checklist – The following should be ready and in the room
1.	Appropriate airway device
2.	Invasive monitoring
3.	Spinal kit with preservative-free morphine
4.	Hemodilution bags x2
5. Albumin 5% 250 ml x2.

1) Anesthesia Techniques
A) Option 1: Intrathecal Morphine (5-10mcg/kg - 0.5 mg MAX) + Remifentanil (0.05-0.4mcg/kg/min). 
(If spinal placement is challenging, have surgeon place spinal or IV methadone).
B) Option 2: IV Methadone 0.2mg/kg + Remifentanil (0.05-0.4mcg/kg/min).
C) Lidocaine: 2 mg/kg iv bolus, 1 mg/kg
D) Phenylephrine drip on standby.
E) BIS goal of 50-60 (adjust propofol).

2) Anti-Fibrinolytic 
Amicar-Load: 100 mg/kg over 30 minutes (max 5 g). Maintenance infusion at 30 mg/kg/hour, continue until skin closure.
TXA- Load: 50 mg/kg over 30 minutes (max 5 g). Maintenance infusion at 5 mg/kg/hour, continue until skin closure.
3) Antibiotics: Cefazolin 25mg/kg, (max 2 g) – Re-dose q4h. 
If allergies: Clindamycin 10mg/kg (Max 900mg). Re-dose q6h or Vancomycin 10mg/kg (Max 1g) Re-dose q6h.
4) Other Medications 
1.	Dexamethasone: 4mg. 
2.	Ondansetron: 4mg 
3.	Diazepam IV 0.05 mg/kg or Methocarbamol (Robaxin): 15mg/kg IV after emergence to treat muscle spasms 
5)  Neuromonitoring: MEP/SSEPs/EMGs typically monitored. Place bilateral soft bite blocks!!!
6) Minimal to no paralysis on intubation. No nitrous. Max 0.5 MAC inhalation agent – Sevoflurane for rapid emergence. 
7) POSTOP ORDERS BEFORE LEAVING OR:
A)  Demand only PCA 
B)  If no IT morphine given: Methadone 0.1mg/kg IV/PO x 2 q6h, timed 6 hours after initial dosing.
C)  Contact the acute pain team add the patient to pain list. 
